ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 225 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $591 | +120.5% | 18,870 | +46.6% | 0.06% | +133.3% |
| Q3 2023 | $268 | -63.6% | 12,873 | -67.1% | 0.03% | -60.3% |
| Q1 2023 | $736 | -99.8% | 39,075 | +80.8% | 0.07% | +94.3% |
| Q3 2022 | $354,000 | -63.9% | 21,618 | -46.6% | 0.04% | -69.8% |
| Q1 2022 | $981,000 | +371.6% | 40,490 | +374.1% | 0.12% | +452.4% |
| Q2 2021 | $208,000 | -39.9% | 8,540 | +19.7% | 0.02% | -59.6% |
| Q2 2020 | $346,000 | +8.5% | 7,137 | -4.4% | 0.05% | +2.0% |
| Q4 2019 | $319,000 | -20.1% | 7,465 | -32.7% | 0.05% | -27.1% |
| Q3 2019 | $399,000 | +94.6% | 11,087 | +44.6% | 0.07% | +100.0% |
| Q2 2019 | $205,000 | -28.8% | 7,667 | -57.0% | 0.04% | -30.0% |
| Q4 2018 | $288,000 | – | 17,815 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
| GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
| Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
| Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
| Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
| Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
| Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
| PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |